ExodusPoint Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $2.77M | Buy |
|
|||||
|
2025
Q2 | $1.89M | Buy |
|
|||||
|
2025
Q1 | $457K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $879K | Sell |
|
|||||
|
2023
Q4 | $1.15M | Sell |
|
|||||
|
2023
Q3 | $5.31M | Sell |
|
|||||
|
2023
Q2 | $8.54M | Sell |
|
|||||
|
2023
Q1 | $10.2M | Buy |
|
|||||
|
2022
Q4 | $251K | Sell |
|
|||||
|
2022
Q3 | $8.94M | Buy |
|
|||||
|
2022
Q2 | $7.5M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.67M | Buy |
|
|||||
|
2021
Q3 | $608K | Sell |
|
|||||
|
2021
Q2 | $1.92M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $171K | Buy |
|